Age, Biography and Wiki

Arthur D. Levinson was born on 31 March, 1950 in Seattle, Washington, United States, is a CEO of CalicoChairman of Apple Inc.. Discover Arthur D. Levinson's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 74 years old?

Popular As N/A
Occupation CEO of CalicoChairman of Apple Inc.
Age 74 years old
Zodiac Sign Aries
Born 31 March, 1950
Birthday 31 March
Birthplace Seattle, Washington, U.S.
Nationality United States

We recommend you to check the complete list of Famous People born on 31 March. He is a member of famous with the age 74 years old group.

Arthur D. Levinson Height, Weight & Measurements

At 74 years old, Arthur D. Levinson height not available right now. We will update Arthur D. Levinson's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Who Is Arthur D. Levinson's Wife?

His wife is Rita May Liff

Family
Parents Malvina and Sol Levinson
Wife Rita May Liff
Sibling Not Available
Children 2

Arthur D. Levinson Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Arthur D. Levinson worth at the age of 74 years old? Arthur D. Levinson’s income source is mostly from being a successful . He is from United States. We have estimated Arthur D. Levinson's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income

Arthur D. Levinson Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Arthur D. Levinson Wikipedia
Imdb

Timeline

2020

In 2020 he received the Bower Award for Business Leadership of the Franklin Institute.

2016

In April 2016, Levinson was awarded the 2016 Distinguished Alumnus Award from the University of California, San Francisco for his contributions to the scientific community.

As of September 2016, he is reported to own approximately 1.2 million Apple shares worth of US$384 million.

2014

In 2014 he received the Alumnus Summa Laude Dignatus Award from the University of Washington, the highest honor bestowed upon a Washington graduate.

On October 3, 2014, Levinson received the National Medal of Technology and Innovation, the nation's highest honor for achievement and leadership in advancing the fields of science and technology.

2013

On September 18, 2013, Levinson was named CEO of Calico, a new company focusing on health and well-being. The company was created and funded by Google.

2011

On November 15, 2011, Levinson was named Chairman of the Board for Apple Inc., replacing Steve Jobs. As the Chairman, his total compensation for 2012 was $457,222.

2010

In 2010, Levinson was honored with the Biotechnology Heritage Award from the Biotechnology Industry Organization (BIO) and the Chemical Heritage Foundation, and the Director's Award from the San Francisco Exploratorium.

2006

In 2006, Princeton University awarded Levinson the James Madison Medal for a distinguished career in scientific research and in biotechnology. Also in 2006, Barron's recognized Levinson as one of "The World's Most Respected CEOs", and Louis Carter, CEO and founder of Best Practice Institute placed Levinson on its "25 Top CEOs" list upon approval of his Senior Executive Board. In 2008 Levinson was elected as a Fellow to the American Academy of Arts and Sciences and Glassdoor rated him as the "nicest" CEO of 2008 with a 93% approval rating.

2003

Levinson was inducted into the Biotech Hall of Fame at the 2003 Biotech Meeting of CEOs. BusinessWeek named Levinson one of the "Best Managers of the Year" in 2004 and 2005, and Institutional Investor named him "America's Best CEO" in the biotech category four years in a row (2004–2007). Levinson served on the Board of Directors of Google from 2004 to 2009.

2000

In addition to serving on the board of Apple Inc. (2000–present), Levinson serves on the board of directors of the Broad Institute (affiliated with MIT and Harvard). Previously, Levinson had served on the board of directors at F. Hoffmann-La Roche (2010-2014), NGM Biopharmaceuticals (2009-2014), and Amyris Biotechnologies (2009-2014). He currently serves on the Board of Scientific Consultants of the Memorial Sloan Kettering Cancer Center, the Industrial Advisory Board of the California Institute for Quantitative Biosciences (QB3), the Advisory Council for the Princeton University Department of Molecular Biology and the Advisory Council for the Lewis-Sigler Institute for Integrative Genomics.

1980

Levinson was a postdoctoral researcher with Nobel Prize winners Michael Bishop and Harold Varmus in the Department of Microbiology at the University of California, San Francisco, when Herb Boyer hired him to work at Genentech. Levinson joined Genentech in 1980 as a research scientist and became Vice President of Research Technology in 1989; Vice President of Research in 1990; Senior Vice President of Research in 1992; and Senior Vice President of Research and Development in 1993. Levinson became Genentech's Chief Executive Officer in 1995 and Chairman in 1999. Levinson received corporate leadership awards from the Irvington Institute and the National Breast Cancer Coalition in 1999.

1978

He married Rita May Liff on December 17, 1978 and they have two children. His son, Jesse Levinson, is currently CTO of Zoox.

1972

Born to a Jewish family, the son of Malvina and Sol Levinson, he received his bachelor's degree from the University of Washington in Seattle in 1972 and his PhD in biochemistry from Princeton University in 1977.

1950

Arthur D. Levinson (born March 31, 1950) is an American businessman and is the current Chairman of Apple Inc. (2011 to present) and CEO of Calico (an Alphabet Inc. venture). He is the former chief executive officer (1995 to 2009) and chairman (1999 to 2014) of Genentech.